Two experts in diabetes discuss how to select and use GLP-1 RAs in clinical practice as part of a multifaceted, patient-centered management plan. Claim your credit at PCE.is/GLP.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now firmly established as guideline-recommended antiglycemic agents of choice in patients with type 2 diabetes, especially when comorbid disease is evident or when the patient is at high risk for such conditions. In this second of two podcasts, Davida Kruger, NP and Anne Peters, MD share tips and pearls for treating patients with type 2 diabetes using GLP-1 RAs, including when to choose a GLP-1 RA, how to broach the topic of a first injectable, when an oral agent is preferred, strategies for encouraging lifestyle modifications, and practical advice on preparing and monitoring patients with respect to GLP1-RA therapy.
This episode is available for CE/CME credit.